Literature DB >> 35282517

Risk Factors for Recurrence of Peptic Ulcer Disease: A Retrospective Study in Tertiary Care Referral Center.

Yaser M Alsinnari1,2, Mohammed S Alqarni1,2, Meshari Attar1,2, Ziad M Bukhari1,2, Mohammed Almutairi1,2, Faisal M Baabbad1,2, Mohammed Hasosah3,1,2.   

Abstract

Backgrounds Peptic ulcer disease (PUD) is a common gastrointestinal tract disease characterized by mucosal damage secondary to pepsin and gastric acid secretion. This study evaluated the five-year recurrence rate for patients with PUD and risk factors contributing to PUD relapses. Methods From 2016 through 2021, all patients with endoscopy-proved PUD were identified by reviewing medical records (Best-Care system). Possible risk factors including smoking, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, alcohol, caffeine, and steroids were analyzed by multivariate analysis. Treatment outcomes, 5-year recurrence rate, and mortality rate were assessed. Results Among 223 patients, there were 187 (83.8%) diagnosed with endoscopy-proved PUD and 36 (16.2%) diagnosed with clinical PUD. Among them, 126 (56.5%) patients were males, and the mean age was 62±2 years. The five years recurrence rate of PUD was 30.9%. There was no significant difference in the recurrence rate between the duodenal ulcer (33.3%) and the gastric ulcer (28.8%). By univariate analysis, the use of steroids and NSAID and Helicobacter pylori (H. pylori) infection were potential risk factors for PUD (P < 0.005). The common complication of PUD was gastrointestinal bleeding (34.1%). Patients who had a complicated PUD were associated with a higher rate of recurrence (45.9%) compared to the uncomplicated PUD (19.2%) (P > 0.05). Conclusion Our findings demonstrated that the five years recurrence rate of PUD was 30.9%. The use of steroids and NSAID and H. pylori infection were risk factors for recurrence of PUD. PUD places a significant burden on health care systems. Therefore, a multicenter prospective study is needed for effective management to prevent recurrence and complications of PUD.
Copyright © 2022, Alsinnari et al.

Entities:  

Keywords:  h pylori infection; peptic ulcer disease; prevalence; recurrence; risk factors

Year:  2022        PMID: 35282517      PMCID: PMC8907029          DOI: 10.7759/cureus.22001

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

Authors:  Francis K L Chan; K F To; Justin C Y Wu; M Y Yung; W K Leung; Timothy Kwok; Y Hui; Henry L Y Chan; Cynthia S Y Chan; Elsie Hui; Jean Woo; Joseph J Y Sung
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 2.  Perforated peptic ulcer - an update.

Authors:  Kin Tong Chung; Vishalkumar G Shelat
Journal:  World J Gastrointest Surg       Date:  2017-01-27

Review 3.  Therapeutics for Equine Gastric Ulcer Syndrome.

Authors:  Fereydon Rezazadeh Zavoshti; Frank M Andrews
Journal:  Vet Clin North Am Equine Pract       Date:  2017-04       Impact factor: 1.792

4.  Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

Authors:  Ángel Lanas; Patricia Carrera-Lasfuentes; Yolanda Arguedas; Santiago García; Luis Bujanda; Xavier Calvet; Julio Ponce; Ángeles Perez-Aísa; Manuel Castro; Maria Muñoz; Carlos Sostres; Luis A García-Rodríguez
Journal:  Clin Gastroenterol Hepatol       Date:  2014-11-14       Impact factor: 11.382

5.  Immunosuppressive agents are associated with peptic ulcer bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

6.  Causal role of Helicobacter pylori in peptic ulcer relapse.

Authors:  M Asaka; T Ohtaki; M Kato; M Kudo; T Kimura; T Meguro; S Horita; K Inoue
Journal:  J Gastroenterol       Date:  1994-07       Impact factor: 7.527

Review 7.  Peptic Ulcer Disease and Helicobacter pylori infection.

Authors:  Mechu Narayanan; Kavya M Reddy; Elizabeth Marsicano
Journal:  Mo Med       Date:  2018 May-Jun

8.  Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study.

Authors:  Monica Pantea; Anca Negovan; Claudia Banescu; Simona Bataga; Radu Neagoe; Simona Mocan; Mihaela Iancu
Journal:  Gastroenterol Res Pract       Date:  2018-11-04       Impact factor: 2.260

9.  Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Chih-Ming Liang; Shih-Cheng Yang; Cheng-Kun Wu; Yu-Chi Li; Wen-Shuo Yeh; Wei-Chen Tai; Chen-Hsiang Lee; Yao-Hsu Yang; Tzu-Hsien Tsai; Chien-Ning Hsu; Seng-Kee Chuah
Journal:  J Clin Med       Date:  2019-10-18       Impact factor: 4.241

10.  Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori.

Authors:  Jae Hyun Seo; Su Jin Hong; Jie-Hyun Kim; Byung-Wook Kim; Sam Ryong Jee; Woo Chul Chung; Ki-Nam Shim; Gwang Ho Baik; Sung Soo Kim; Sang Gyun Kim; Jin Il Kim
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

View more
  1 in total

Review 1.  Gastroduodenal injury and repair: novel targets for therapeutic intervention.

Authors:  Susan J Hagen
Journal:  Curr Opin Gastroenterol       Date:  2022-11-01       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.